Biotech Valuation Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation

CRSP 52.51

+2.7%

3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: John Metcalf who wrote (5575)	1/29/2002 10:41:14 AM
From: Robohogs	Read Replies (1) of 52153

ELN is supposed to show some clarity at time of earnings call - that is why in front of earnings. So the fall is Enron/Tyco-related (wow - look at TYC go). The drug failure helped. Maximum uncertainty with no quick prospect for it to go away leads to safe shorting. Buyers are scared, see stock plunging and doubt what they believe causing a lack of buyers vs. strong sellers. I would imagine we are now seeing covering of the shorts into the release of earnings. Nasdaq site (www.nasdaq.com) has short statistics. Jon

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next